Valproic acid-induced encephalopathy: A review of clinical features, risk factors, diagnosis, and treatment

J Wu, J Li, W Jing, X Tian, X Wang - Epilepsy & Behavior, 2021 - Elsevier
Valproic acid (VPA), or sodium valproate, is a commonly used medication for seizure
disorders, migraines, and mental illness. Although VPA is relatively safe, it still has several …

Valproate-induced hyperammonemic encephalopathy: a case report

S Shah, R Wang, U Vieux - Journal of medical case reports, 2020 - Springer
Background Hyperammonemic encephalopathy is a rare and serious adverse reaction to
valproate. Although there is documentation of this reaction in previous reports, very little is …

Total valproate versus free valproate in therapeutic drug monitoring for bipolar disorder: A cross‐sectional study

MBN Krishna, JC Seetharam, A Mishra… - Asia‐Pacific …, 2024 - Wiley Online Library
Introduction The debate about observing total versus free serum valproate levels for
therapeutic drug monitoring (TDM) has been unresolved for decades. This study was …

Hyperammonemia in patients with status epilepticus treated with or without valproic acid

KM Smith, JW Britton, SE Hocker, M Toledano - The Neurologist, 2021 - journals.lww.com
Background: Hyperammonemia is a common side effect of valproic acid (VPA) and can
occur after generalized seizures, but the clinical significance is unclear. The aim of this study …

Recurrent hyperammonemia associated with olanzapine

YF Wu - Journal of clinical psychopharmacology, 2017 - journals.lww.com
DISCUSSION Hyperammonemia is a metabolic condition characterized by elevated serum
levels of ammonia. Decreased ammonia elimination may occur as a result of hepatic failure …